Scientists at the New York Stem Cell Foundation (NYSCF) Research Institute have come a step closer to developing a replacement therapy for the treatment of MS patients using patients’ own stem cells.

An international research team has discovered 83 previously unknown gene regions suspected to be associated with schizophrenia. The scientists examined genes from 36,989 patients and from 113,075 control subjects.

The Center of Alternatives to Animal Testing (CAAT)-Europe is an academic research center and communication platform. Candidates that are highly motivated to strengthen the collaboration between the public, academia, the private sector, regulatory agencies, and other stakeholders in the field of animal-free toxicity testing are invited to apply for the position.

With the help of patients’ material, researchers from the German Center for Neurodegenerative Diseases (DZNE) and the Hertie Institute for Clinical Brain Research in Tübingen have found out that people with a variant of the gene GBA1 bear an increased risk of developing Parkinson's disease.